Binimetinib is a pharmaceutical raw material that functions as a selective inhibitor of MEK, a key enzyme in the MAPK signaling pathway. It is supplied for use in research and manufacturing of anti-cancer therapeutics.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Binimetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Selumetinib sulfate
pharmaceutical raw material
Bifonazole
pharmaceutical raw material
Grass Valley edit decision list
pharmaceutical raw material
Butylphthalide
pharmaceutical raw material
Elcatonin
pharmaceutical raw material
The international HS code for Binimetinib (CAS 606143-89-9) is 2933.99.
2933.99
2933 99 80
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide
ACWZRVQXLIRSDF-UHFFFAOYSA-N
CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO
Sourcing Binimetinib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.